[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"intramural-hematoma-of-the-thoracic-aorta\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:intramural-hematoma-of-the-thoracic-aorta":53},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":31,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":52},"100643960",false,"NCT07668687","European Multi-Centre Post-Market Registry on Thoracic Endovascular Arch Repair Using Castor™ and Cratos™","European Multi-Centre Castor™ and Cratos™ Branched Endovascular Arch Repair Registry","CEDAR","Inclusion Criteria:\n\n* Implantation of a Castor™ or Cratos™ single branch endoprothesis with incorporation of the left subclavian artery\n* Age \\>18 years\n\nExclusion Criteria:\n\n* Patients allergic to the materials of the device;\n* Patients with severe or potentially systemic infections that increase the chance of graft infection;\n* Minors and pregnant women;\n* Branch for other supra-aortic vessels than the LSA\n* Rejection of participation.","ALL","18 Years",{"count":19,"type":20},100,"ESTIMATED","5 Years","OBSERVATIONAL","The Castor™ and Cratos™ Branched Aortic Stent Graft Systems are medical devices designed for the minimally invasive endovascular treatment of thoracic aortic pathologies in the descending aorta. The goal of this multi-centre retrospective and prospective observational registry study is to capture the short-, medium- to long-term safety and performance data of how Castor™ and Cratos™ stent-grafts work in real-world settings (everyday medical practice). The aim is to study approximately 100 patients in European hospitals, with competitive enrollment.",[25,26,27,28,29,30],"Dissection of Thoracic Aorta","Dissection of Thoracic Descending Aorta","Aneurysm of Aorta, Thoracic","Penetrating Aortic Ulcers (PAUs)","Intramural Hematoma of the Thoracic Aorta","Ulcer-like Projection (ULP)",[32,33,34,35,36,37,38,39],"Castor™ Branched Aortic Stent Graft System","Cratos™ Branched Aortic Stent Graft System","TEVAR","thoracic aortic aneurysm (TAA)","Penetrating Aortic Ulcer (PAU)","Aortic Intramural Haematoma (IMH)","Ulcer-like projection (ULP)","thoracic aortic dissection","RECRUITING","2026-06-23",{"date":43,"type":44},"2026-06-25","ACTUAL",{"date":46,"type":44},"2025-09-12",{"date":48,"type":20},"2033-12",{"name":50,"class":51},"Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd","INDUSTRY",4,""]